Cataracc Liquid
NDC Package 55714-4847-1
Package Information
Cataracc (arsenicum alb., bryonia, calc. fluor., calendula, causticum, conium, euphrasia, hydrofluoricum ac., iodium, ledum, naphthalinum, nat. mur., nux vom., phos., pulsatilla, sepia, silicea, tellurium, thiosinaminum, zinc. met.) liquids is formulated for symptoms such as blurred vision, light sensitivity and opacities. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4847.
Identification & Billing
Clinical Specifications
- ALLYLTHIOUREA 15 [hp_X]/mL
- ANEMONE PULSATILLA 15 [hp_X]/mL
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CALCIUM FLUORIDE 15 [hp_X]/mL
- CALENDULA OFFICINALIS FLOWERING TOP 15 [hp_X]/mL
- CAUSTICUM 15 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP 15 [hp_X]/mL
- EUPHRASIA STRICTA 15 [hp_X]/mL
- HYDROFLUORIC ACID 15 [hp_X]/mL
- IODINE 15 [hp_X]/mL
- NAPHTHALENE 15 [hp_X]/mL
- PHOSPHORUS 15 [hp_X]/mL
- RHODODENDRON TOMENTOSUM LEAFY TWIG 15 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 15 [hp_X]/mL
- SILICON DIOXIDE 15 [hp_X]/mL
- SODIUM CHLORIDE 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- TELLURIUM 16 [hp_X]/mL
- ZINC 15 [hp_X]/mL
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4847 - Cataracc
- 55714-4847-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4847 - Cataracc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4847-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Cataracc, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains allylthiourea; anemone pulsatilla; arsenic trioxide; bryonia alba root; calcium fluoride; calendula officinalis flowering top; causticum; conium maculatum flowering top; euphrasia stricta; hydrofluoric acid; iodine; naphthalene; phosphorus; rhododendron tomentosum leafy twig; sepia officinalis juice; silicon dioxide; sodium chloride; strychnos nux-vomica seed; tellurium; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 30, 2022. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714484701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.